Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-18

FDA Approved: FOMEPIZOLE — Supplemental Application (Navinta LLC)

View source ↗

Summary

FDA approved a supplemental Abbreviated New Drug Application for fomepizole from Navinta LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fomepizole (fomepizole)

Snippet

SUPPL AP for FOMEPIZOLE (FOMEPIZOLE)